|
The customer, dompe farmaceutici spa, contacted the device manufacturer on 22apr2026 to report during packaging of the swabable vial adapter (sva) with the customer's drug product, foreign particles were detected within the primary packaging of the devices and also within the sealing area of the primary packaging.The customer confirmed that the affected devices are segregated, not for use.This deficiency was found prior to use.The device had not yet entered into the distribution stage to the end user (i.E.Being put into service), there was no health impact to the end user.
|